Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baruchel

Showing results (301-310 of 590) with videos related to

Pageof 59
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 18, 2013
[Development of psychological and intellectual performance in transplanted sickle cell disease patients: a prospective study from pretransplant period to 5 years after HSCT]J Bockenmeyer, E Chamboredon, F Missud, et al.
Bone Marrow Transplantation|February 1, 1996
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, G Leverger, T Leblanc, et al.
Bone Marrow Transplantation|March 31, 2015
Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TCM Strullu, C Thomas, M-C Le Deley, et al.
British Journal of Haematology|November 14, 1997
The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcriptsA Baruchel, J M Cayuela, P Ballerini, et al.
Pediatric Hematology and Oncology|January 6, 2018
Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trialAnne-Charlotte Teyssier, Hélène Lapillonne, Marlene Pasquet, et al.
Blood Advances|August 9, 2020
In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failureMathieu Simonin, Anne Auperin, Yves Bertrand, et al.
Leukemia|June 29, 2021
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocolsMary M Taj, Anthony V Moorman, Lina Hamadeh, et al.
British Journal of Haematology|January 6, 2016
Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective studyJulie Sommet, Corinne Alberti, Nathalie Couque, et al.
Lancet (London, England)|June 12, 2002
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal regionChing-Hon Pui, Paul S Gaynon, James M Boyett, et al.
Leukemia|November 6, 2014
Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosisS Poglio, X Cahu, B Uzan, et al.
Pageof 59

Showing results (301-310 of 590) with videos related to

Sort By:
Pageof 59
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 18, 2013
[Development of psychological and intellectual performance in transplanted sickle cell disease patients: a prospective study from pretransplant period to 5 years after HSCT]J Bockenmeyer, E Chamboredon, F Missud, et al.
Bone Marrow Transplantation|February 1, 1996
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, G Leverger, T Leblanc, et al.
Bone Marrow Transplantation|March 31, 2015
Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TCM Strullu, C Thomas, M-C Le Deley, et al.
British Journal of Haematology|November 14, 1997
The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcriptsA Baruchel, J M Cayuela, P Ballerini, et al.
Pediatric Hematology and Oncology|January 6, 2018
Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trialAnne-Charlotte Teyssier, Hélène Lapillonne, Marlene Pasquet, et al.
Blood Advances|August 9, 2020
In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failureMathieu Simonin, Anne Auperin, Yves Bertrand, et al.
Leukemia|June 29, 2021
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocolsMary M Taj, Anthony V Moorman, Lina Hamadeh, et al.
British Journal of Haematology|January 6, 2016
Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective studyJulie Sommet, Corinne Alberti, Nathalie Couque, et al.
Lancet (London, England)|June 12, 2002
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal regionChing-Hon Pui, Paul S Gaynon, James M Boyett, et al.
Leukemia|November 6, 2014
Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosisS Poglio, X Cahu, B Uzan, et al.
Pageof 59